BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 7931292)

  • 1. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD; Yu JS; Shiah SG; Huang JJ
    J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain.
    Song JS; Yang SD
    J Protein Chem; 1995 Feb; 14(2):95-105. PubMed ID: 7786411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD; Song JS; Yu JS; Shiah SG
    J Neurochem; 1993 Nov; 61(5):1742-7. PubMed ID: 8228990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic control mechanism for abnormal site phosphorylation of Alzheimer's diseased brain tau by kinase FA/GSK-3 alpha.
    Yang SD; Yu JS; Liu WK; Yen SH
    Biochem Biophys Res Commun; 1993 Dec; 197(2):400-6. PubMed ID: 7505567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.
    Paudel HK; Lew J; Ali Z; Wang JH
    J Biol Chem; 1993 Nov; 268(31):23512-8. PubMed ID: 8226879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of tau phosphorylation at different sites in Alzheimer disease brain.
    Ikura Y; Kudo T; Tanaka T; Tanii H; Grundke-Iqbal I; Iqbal K; Takeda M
    Neuroreport; 1998 Jul; 9(10):2375-9. PubMed ID: 9694231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry.
    Yoshimura Y; Ichinose T; Yamauchi T
    Neurosci Lett; 2003 Dec; 353(3):185-8. PubMed ID: 14665412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
    Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
    J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase.
    Wang JZ; Wu Q; Smith A; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 1998 Sep; 436(1):28-34. PubMed ID: 9771888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin).
    Moreno FJ; Medina M; Pérez M; Montejo de Garcini E; Avila J
    FEBS Lett; 1995 Sep; 372(1):65-8. PubMed ID: 7556645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase FA/glycogen synthase kinase-3 predominantly phosphorylates the in vivo site Thr97-Pro in brain myelin basic protein: evidence for Thr-Pro and Ser-Arg-X-X-Ser as consensus sequence motifs.
    Yu JS; Yang SD
    J Neurochem; 1994 Apr; 62(4):1596-603. PubMed ID: 7510785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP; Hughes K; Woodgett JR; Brion JP; Anderton BH
    Neurosci Lett; 1992 Nov; 147(1):58-62. PubMed ID: 1336152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locations and immunoreactivities of phosphorylation sites on bovine and porcine tau proteins and a PHF-tau fragment.
    Poulter L; Barratt D; Scott CW; Caputo CB
    J Biol Chem; 1993 May; 268(13):9636-44. PubMed ID: 8486651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain.
    Godemann R; Biernat J; Mandelkow E; Mandelkow EM
    FEBS Lett; 1999 Jul; 454(1-2):157-64. PubMed ID: 10413115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.
    Biernat J; Gustke N; Drewes G; Mandelkow EM; Mandelkow E
    Neuron; 1993 Jul; 11(1):153-63. PubMed ID: 8393323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.